Human ROR genes are identified as modulators of the p21 pathway, and thus are therapeutic targets for disorders associated with defective p21 function. Methods for identifying modulators of p21, comprising screening for agents that modulate the activity of ROR are provided.

 
Web www.patentalert.com

< Transgenic clawed frog embryos and use thereof as detectors of endocrine disrupters in the environment

< Lymphocyte surface receptor that binds CAML and methods of use thereof

> Animal models of cancer development and metastasis

> Methods for the identification of compounds for the treatment of Alzheimer's disease
~ 00260